Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Simply Wall St08:56 ET

Express News | AtriCure Receives Expanded Indication For AtriClip In Europe For High-Risk Thromboembolism Patients, Validating Its Effectiveness In Reducing Stroke Events During Cardiac Surgery

Benzinga08:03 ET

Express News | AtriCure Receives Expanded Ce-Mark Indication for Atriclip® Devices for the Reduction of Stroke in Patients With Atrial Fibrillation

Reuters08:01 ET

AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices for the Reduction of Stroke in Patients With Atrial Fibrillation

Businesswire08:00 ET

CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsAug 14 07:31 ET · Ratings

Atricure's Market Strength and Innovation Justify Buy Rating

TipRanksAug 14 07:16 ET · Ratings